26 filings · most recent first
ABT 8-K Filings
Abbott Laboratories Reports Strong Q2 2026 Results And Raises Fullyear Eps
Abbott Laboratories Appoints New Board Member And Adopts New Incentive Stock
Abbott Laboratories Announces Proposed Settlement In Shareholder Derivative
Abbott Laboratories Announces Firstquarter 2026 Results And Acquisition Of
Abbott Completes Acquisition Of Exact Sciences Strengthening Cancer Diagnostics
Abbott Laboratories Completes 20 Billion Senior Notes Offering To Fund Exact
Abbott Laboratories Announces Issuance Of Senior Notes To Fund Exact Sciences
Abbott Laboratories Amends Board Size In Bylaws
Abbott Laboratories Announces 2025 Results And 2026 Outlook
Abbott Laboratories Announces Thirdquarter 2025 Results And Reaffirms Guidance
Abbott Laboratories Announces Secondquarter 2025 Results And Guidance
Abbott Reports Firstquarter 2025 Financial Results With Organic Sales Growth
Abbott Laboratories Reports Strong Fourth Quarter And Full Year 2024 Financial
Abbott Laboratories Announces Thirdquarter 2024 Results And Raises Eps Guidance
Abbott Laboratories Reports Q2 2024 Results And Raises Fullyear Guidance
Abbott Reports Q1 2024 Results And Raises Guidance
Abbott Laboratories Reports Fourthquarter And Fullyear 2023 Financial Results
Abbott Laboratories Announces New Board Member And Bylaw Amendments
Abbott Laboratories Announces Blackout Period For Employee Benefit Plans
Abbott Laboratories Announces Agreement To Acquire Exact Sciences For 21 Billion
Retirement Of Abbott Laboratories Executive Vice President General Counsel And
Abbott Laboratories Announces Annual Meeting Results
Abbott Laboratories Extends Executive Agreements
Robert E Funck Jr To Retire From Abbott Laboratories
Abbott Laboratories Shareholders Approve Director Elections And Auditor
Abbott Laboratories Enters New Fiveyear Revolving Credit Agreement